Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients
Prapas N, Tavaniotou A, Panagiotidis Y, Prapa S, Kasapi E, Goudakou M, Papatheodorou A, Prapas Y.
Iakentro Fertility Centre, Ag. Vasiliou 4 Street, Thessaloniki, Greece.
Gynecol Endocrinol. 2009 Jan;25(1):53-9.
Abstract
The effect of low-dose human chorionic gonadotropin (hCG) administration in the proliferative phase of oocyte recipients was investigated in a prospective randomized trial. Sibling oocytes from the same donor were shared at random among two different recipients. In group I oocyte recipients received 750 IU of hCG every three days concomitant to endometrial preparation with estradiol until hCG injection to the donor, whereas in group II recipients received no hCG during endometrial priming with estradiol. Endometrial thickness was significantly lower in group I compared with group II, although similar endometrial thickness was detected during the mock cycle. Pregnancy rates were significantly lower in group I than in group II (13.6% vs. 45.4%, p<0.05). Implantation rates were also significantly lower in group I (1.7% vs. 22.4%, p<0.01). The study was discontinued prematurely for ethical reasons when 22 cycles were completed, as pregnancy rates were very low in group I. In conclusion, hCG administration in the proliferative phase might directly affect endometrial proliferation and receptivity.
Publications abstracts in peer reviewed journals
-
Cecal volvulus after twin gestation: laparoscopic approach
-
Comparison between different routes of progesterone administration as luteal phase support in infertility treatments
-
Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
-
Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
-
Endometrial hormone receptors and proliferation index on the day of ovum pick-up in GnRH analogue/hMG stimulated cycles with embryo transfer. Comparison to natural cycles and relation to clinical pregnancies
-
Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization.
-
GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial
-
Impact of ovarian stimulation on corpus luteum function and embryonic implantation
-
Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients
-
Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
-
Ovulation induction disrupts luteal phase function.
-
The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate / gonadotrophin / 0.25 mg cetrorelix